The finalists for the 2026 CPHI Pharma Awards span15 categories including API development, digital transformation, manufacturing, supply chain, sustainability, and leadership, with winners revealed ...
In part 1 of this 2-part preview of AAPS PharmSci 360’s keynote on predictive drug development, Robert Holt, PhD, associate director, Pharmaceutical Science, digiM Solution, explains microstructure ...
David S. Thompson, CSAP, is Chief Alliance Officer at Eli Lilly and Company.
Marco Anelli, MD | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.
In August 2026, Heidi Overton was nominated for FDA commission, and a wave of oncology and neuro drugs were approved. In August 2026, a new FDA commissioner was nominated by the White House; there was ...
On August 31, 2026, Eli Lilly announced it has entered a definitive agreement to acquire Merida Biosciences, a biotechnology ...
This episode of PharmTech Explained discusses how China's biotech surge is reshaping US drug licensing, manufacturing control, and FDA data trust, the key shifts pharma professionals must track.
The FDA cleared four notable therapies within the same week in late August, spanning infectious disease, cardiometabolic care ...
In part 2 of his overview on hold times in biopharmaceuticals, Robert Dream details the regulations that govern hold times and how to mitigate risks that can occur during hold times.
This article explores strategies for formulating complex and emerging biologics, the role of predictive modeling, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results